BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 5909253)

  • 1. The long-term effectiveness of methyldopa in hypertension.
    Okun R; Roth SE; Gordon A; Maxwell MH
    Calif Med; 1966 Jan; 104(1):46-50. PubMed ID: 5909253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A comparative evaluation of metoprolol and methyldopa in hypertension therapy (author's transl)].
    Muiesan G; Agabiti-Rosei E; Buoninconti R; Carotti A; Fariello R; Innocenti P; Solinas E; Toso M; Motolese M
    G Ital Cardiol; 1980; 10(11):1482-90. PubMed ID: 7202896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methyldopa: an agent for the treatment of older patients with isolated systolic hypertension.
    Vaicaitis JS
    Clin Ther; 1984; 6(4):451-6. PubMed ID: 6467278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydrochlorothiazide plus methyldopa in the treatment of isolated systolic hypertension in the elderly.
    Boyles PW
    Clin Ther; 1984; 6(6):793-9. PubMed ID: 6509462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative study of metoprolol and methyldopa in the treatment of hypertension.
    Karachalios GN
    Int J Clin Pharmacol Ther Toxicol; 1983 Sep; 21(9):476-8. PubMed ID: 6629553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Long-range therapy of hypertension].
    Szám I; Radó J; Takó J
    Z Gesamte Inn Med; 1976 Feb; 31(3):321-4. PubMed ID: 960892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicentric, clinical trial of S-Amlodipine 2.5 mg versus Amlodipine 5 mg in the treatment of mild to moderate hypertension--a randomized, double-blind clinical trial.
    Pathak L; Hiremath ; Kerkar PG; Manade VG
    J Assoc Physicians India; 2004 Mar; 52():197-202. PubMed ID: 15636308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term treatment of hypertension with methyldopa. IV. Duration of methyldopa therapy.
    del Greco F; Huang CM; Quintanilla A
    J Cardiovasc Pharmacol; 1981; 3 Suppl 2():S99-103. PubMed ID: 6172673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of indoramin and methyldopa in hypertension.
    Rosendorff C
    S Afr Med J; 1976 May; 50(20):764-8. PubMed ID: 779054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of essential and nephrogenic hypertension using alpha-methyldopa and alpha-methyldopa+hydrochlorothiazide. Comparative study].
    Sales EJ; Villa JJ; Mendez MA
    Prensa Med Argent; 1971 Jun; 58(14):741-8. PubMed ID: 5091433
    [No Abstract]   [Full Text] [Related]  

  • 11. [Controllable hypertension therapy with Tadip].
    Schütz E
    Med Klin; 1971 Jan; 66(4):121-6. PubMed ID: 5546736
    [No Abstract]   [Full Text] [Related]  

  • 12. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
    J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of the anti-hypertensive effect of spironolactone: trial of combined therapy with spironolactone and alpha-methyldopa].
    Cagli V
    Clin Ter; 1976 Feb; 76(3):253-60. PubMed ID: 963964
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative antihypertensive effects of guanabenz and methyldopa.
    Walker BR; Deitch MW; Schneider BE; Hare LE
    Clin Ther; 1981; 4(4):275-84. PubMed ID: 7332915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Alpha-methyldopa in the treatment of arterial hypertension. Clinical study of 150 patients].
    Ferrario G
    Minerva Med; 1973 Apr; 64(21):1098-103. PubMed ID: 4703861
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term treatment of Hypertension with methyldopa. II. Therapeutic efficacy.
    Fitz AE; Saunders E
    J Cardiovasc Pharmacol; 1981; 3 Suppl 2():S85-91. PubMed ID: 6172671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A controlled comparison of the antihypertensive effects of labetalol and alpha-methyldopa.
    Al-Damluji SF; Al-Khalidi A; Shaarbaf H; Tawfiq NH
    Pharmatherapeutica; 1982; 3(2):133-9. PubMed ID: 7048338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Guanfacine versus alpha-methyldopa in benign essential hypertension. An ambulatory group study].
    Rhomberg F; Widler J
    Schweiz Med Wochenschr; 1981 Dec; 111(50):1967-8. PubMed ID: 7036334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Self-control of the blood pressure in hypertension therapy].
    Enger E
    Tidsskr Nor Laegeforen; 1972 Feb; 92(4):257-63. PubMed ID: 5016488
    [No Abstract]   [Full Text] [Related]  

  • 20. [Dopegyt (alpha-methyldopa) in arterial hypertension].
    Kedra M; Koziara Z
    Pol Tyg Lek; 1971 Jun; 26(25):963-5. PubMed ID: 5564519
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.